Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Mettler Toledo Launches the Oxygen Sensors for Biopharma Applications

Published: Monday, November 12, 2012
Last Updated: Sunday, November 11, 2012
Bookmark and Share
Advanced optical technology raises the benchmark for easy handling combined with exceptional performance.

Mettler Toledo Process Analytics has announced the launch of the InPro 6860i, a series of dissolved oxygen (DO) sensors for the biopharma industry.

InPro 6860i sensors combine a highly accurate and reliable optical measurement technique with automatic drift compensation and plug-and-measure installation.

Central to the operational benefits of the new sensors is Mettler Toledo's Intelligent Sensor Management (ISM) concept, simplifying sensor handling and maintenance with advanced features not available on non-ISM sensors.

ISM's predictive diagnostics enable operators to determine easily lnPro 6860i sensors require maintenance before its next use. Sensors based on optical measurement are favored in biofermentation processes as they exhibit low drift.

With the InPro 6860i, any drift that occurs is automatically compensated for by the ISM technology. These two features provide high measurement stability and assure batch-to-batch consistency maintenance.

For installation flexibility, InPro 6860i DO sensors output a digital signal for use with ISM transmitters and an analog (nA) signal for biocontrollers.

Hygienic design requirements are addressed with a Teflon® coated and O-ring-free sensing element which resists biofouling and is easily cleaned.

"Mettler Toledo’s new DO sensors offer unequalled performance and ease of handling,” says Jürgen Illerhaus, head of product management at Mettler Toledo Process Analytics.”

Combined with the outstanding robustness and user friendliness of the sensor, we are able to meet the demanding process requirements from direct integration in bench top fermenters to validated production processes."


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Pharma Tech Trends and Development Cost Solutions
METTLER TOLEDO’s new on-demand webinar, “Methods to Improve Chemical Process Development,” takes on the challenges of today’s pharmaceutical market.
Thursday, April 04, 2013
Scientific News
Researchers Discover Immune System’s 'Trojan Horse'
Oxford University researchers have found that human cells use viruses as Trojan horses, transporting a messenger that encourages the immune system to fight the very virus that carries it.
How to Become a Follicular T Helper Cell
Uncovering the signals that govern the fate of T helper cells is a big step toward improved vaccine design.
First Artificial Ribosome Designed
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Ferring Bets on Bacteriophages to Treat Inflammatory Bowel Disease
Ferring Pharmaceuticals have annoucned that it will collaborate with Intralytix in the latest phase of its early stage development programme for a bacteriophage-based therapy for inflammatory bowel disease (IBD).
A Novel Drug to FIght Malaria
An international team of scientists has announced that a new compound to fight malaria is ready for human trials.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!